Ionic Advisors offers a highly specialized approach to assisting companies with strategy formation, competitive landscaping and posturing, valuations, board and executive recruitment, and strategics and investor targeting and outreach. Primarily working in the life sciences and healthcare industry, a combination of industry expertise, scientific understanding, and strong networks make us a powerful partner in shaping perception and driving business success.
Ionic Advisors collaborates closely with our clients to ensure a streamlined and efficient process, while simultaneously fostering competitive tension and enhancing value. We provide expert guidance and deliver value-added services throughout the M&A process, keeping all parties aligned towards a successful transaction. Areas of expertise include: asset specific or whole company seller side representation, buy-side acquisition services, joint ventures, and going private transactions.
Ionic Advisors' established relationships in capital markets, private equity firms, family offices, senior debt providers, and other institutional financing sources allow us to take a a proactive, thoughtful and data-driven approach tailored for our clients in targeting the right financing partners. We spend the time to fully understand our client's objectives and each fund’s investment criteria and current portfolio, enabling us to effectively identify and connect with those that align with our clients' specific needs, including industry, size, stage, and other key factors.

PRESIDENT, FOUNDER
Mr. Thompson is an executive with over 20 years of operational leadership responsibilities across financial, manufacturing and biotechnology industries with the last ten years dedicated to deal-making in life sciences. Deep understanding of market participants and proven success in evaluation, valuation and negotiation for licensing, financing and M&A.

SENIOR ADVISOR
Mr. Abe has over 30 years extensive international experience as General Counsel to Japanese global corporations and in the global pharmaceuticals industry as business development, licensing and alliance management. Previously General Counsel at Fast Retailing Co., Ltd and Kokuyo Co., Ltd and Corporate officer in charge of Global Business Development and Global Alliance Management at SymBio Pharmaceuticals Limited.

SENIOR ADVISOR
Dr. Pullan is the founder of Pullan Consulting, a trusted advisory firm specializing in biotech and pharmaceutical business development. Holding a Ph.D. in Biochemistry and more than 30 years in the industry—including roles at Amgen, Kosan Biosciences, AstraZeneca, and others—she advises biotech innovators worldwide, teaches negotiation masterclasses, serves on boards, and shares insights through her monthly newsletter, Pullan’s Pieces.
Westlake Village, California, United States
Ionic Advisors, LLC. offers securities through Finalis Securities LLC; Office of Supervisory Jurisdiction is located at 450 Lexington Ave, New York, NY 10017, 800-962-0418
Securities are offered through Finalis Securities LLC Member FINRA / SIPC. Ionic Advisors LLC is not a registered broker-dealer, and Finalis Securities LLC and Ionic Advisors LLC are separate, unaffiliated entities. Finalis Securities LLC, Office of Supervisory Jurisdiction is located at 450 Lexington Ave, New York, NY 10017, 800-962-0418. Supervised at 450 Lexington Ave, New York, NY 10017.
Finalis Privacy Policy | Finalis Business Continuity Plan | FINRA BrokerCheck | Finalis Form Customer Relationship Summary (“Form CRS”)
https://www.ionicadvisors.com (the "Ionic Advisors LLC Website") is a website operated by Ionic Advisors LLC. This website is for informational purposes only, is not an offer, solicitation, recommendation, or commitment for any transaction or to buy or sell any security or other financial product, and is not intended as investment advice or as a confirmation of any transaction. Products and services on this website may not be available for residents of certain jurisdictions. Please consult with a Finalis Securities’ registered representative regarding the product or service in question for further information. Investments involve risk and are not guaranteed to appreciate. Any market price, indicative value, estimate, view, opinion, data, or other information herein is not warranted as to completeness or accuracy, is subject to change without notice, and Ionic Advisors LLC along with Finalis Securities LLC accepts no liability for its use or to update it or keep it current.
Investing in private placements involves a high degree of risk. These investments may be illiquid, speculative, and subject to substantial restrictions on transferability. Investors may lose all or part of their investment and should only invest capital they can afford to lose. Prospective investors should conduct their own due diligence and consult with their legal, tax, and financial advisors prior to making any investment decision. For your reference, Finalis’ Form CRS describes the services that we provide, how we are compensated, and other important information about Finalis Securities LLC.
Copyright © 2026 Ionic Advisors, LLC - All Rights Reserved.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.